Warning: The NCBI web site requires JavaScript to function. more...
Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis.
Goëb V, Dieudé P, Vittecoq O, Mejjad O, Ménard JF, Thomas M, Gilbert D, Boumier P, Pouplin S, Daragon A, Fardellone P, Tron F, Cornélis F, Le Loët X.
Arthritis Res Ther. 2005;7(5):R1056-62. Epub 2005 Jun 29.
Related citations
Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V, Dieudé P, Daveau R, Thomas-L'otellier M, Jouen F, Hau F, Boumier P, Tron F, Gilbert D, Fardellone P, Cornélis F, Le Loët X, Vittecoq O.
Rheumatology (Oxford). 2008 Aug;47(8):1208-12. Epub 2008 Jun 5.
Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis.
Constantin A, Dieudé P, Lauwers-Cancès V, Jamard B, Mazières B, Cambon-Thomsen A, Cornélis F, Cantagrel A.
Arthritis Rheum. 2004 Mar;50(3):742-7.
The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins.
Graudal N.
Scand J Rheumatol Suppl. 2004;118:1-38.
Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity.
Dieudé P, Petit E, Cailleau-Moindrault S, Osorio J, Pierlot C, Martinez M, Fauré S, Alibert O, Lasbleiz S, De Toma C, Bardin T, Prum B, Cornélis F; European Consortium on Rheumatoid Arthritis Families.
Arthritis Rheum. 2002 Aug;46(8):2039-44.
Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation.
Stark GL, Dickinson AM, Jackson GH, Taylor PR, Proctor SJ, Middleton PG.
Transplantation. 2003 Dec 27;76(12):1742-9.
HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias.
Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, Bruce B.
Arthritis Rheum. 2002 Sep;46(9):2320-9.
Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids.
Sanmartí R, Gómez-Centeno A, Ercilla G, Larrosa M, Viñas O, Vazquez I, Gómez-Puerta JA, Gratacós J, Salvador G, Cañete JD.
Clin Rheumatol. 2007 Jul;26(7):1111-8. Epub 2006 Nov 16.
Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis.
Morita C, Horiuchi T, Tsukamoto H, Hatta N, Kikuchi Y, Arinobu Y, Otsuka T, Sawabe T, Harashima S, Nagasawa K, Niho Y.
Arthritis Rheum. 2001 Dec;44(12):2819-27.
Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
Fabris M, Tolusso B, Di Poi E, Assaloni R, Sinigaglia L, Ferraccioli G.
J Rheumatol. 2002 Sep;29(9):1847-50.
The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G.
Arthritis Rheum. 2009 Mar;60(3):698-707.
The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years.
Rau R, Herborn G, Zueger S, Fenner H.
J Rheumatol. 2000 Nov;27(11):2566-75.
A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity.
Gourraud PA, Boyer JF, Barnetche T, Abbal M, Cambon-Thomsen A, Cantagrel A, Constantin A.
Arthritis Rheum. 2006 Feb;54(2):593-9.
Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study.
Constantin A, Lauwers-Cancès V, Navaux F, Abbal M, van Meerwijk J, Mazières B, Cambon-Thomsen A, Cantagrel A.
Arthritis Rheum. 2002 Jul;46(7):1754-62.
Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study.
J Rheumatol. 2002 Jan;29(1):15-20.
No genetic association between tumour necrosis factor receptor II 196R polymorphism and Japanese sporadic Alzheimer's disease.
Shibata N, Ohnuma T, Takahashi T, Matsubara Y, Ueki A, Nagao M, Arai H.
Psychiatr Genet. 2004 Mar;14(1):53-5.
Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis.
Vasilopoulos Y, Bagiatis V, Stamatopoulou D, Zisopoulos D, Alexiou I, Sarafidou T, Settas L, Sakkas L, Mamouris Z.
Clin Exp Rheumatol. 2011 Jul-Aug;29(4):701-4. Epub 2011 Sep 1.
Influence of FCGR3A-V212F and TNFRSF1B-M196R genotypes in patients with rheumatoid arthritis treated with infliximab therapy.
Rooryck C, Barnetche T, Richez C, Laleye A, Arveiler B, Schaeverbeke T.
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):340-2.
Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients.
Hussein YM, Mohamed RH, Pasha HF, El-Shahawy EE, Alzahrani SS.
Cell Immunol. 2011;271(1):192-6. Epub 2011 Jun 29.
Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort.
Khanna D, Wu H, Park G, Gersuk V, Gold RH, Nepom GT, Wong WK, Sharp JT, Reed EF, Paulus HE, Tsao BP; Western Consortium of Practicing Rheumatologists.
Arthritis Rheum. 2006 Apr;54(4):1105-16.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on